MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Ethyol (amifostine)

Company: Alza
Approval Status: Approved December 8, 1995
Treatment for: ovarian cancer
Areas: Diabetes / Endocrinology; Pregnancy & Gynecology; Cancer & Oncology
Possible similar drugs: Ethyol

| General Information | Clinical Results | Side Effects | Literature References |


General Information

Ethyol has been approved to reduce the renal toxicity associated with repeated administration of chemotherapy in subjects with advanced ovarian cancer. Currently, there are only limited data on the effects of Ethyol on the efficacy of chemotherapy in other settings. Ethyol should not be administered to patients receiving chemotherapy for malignancies that are commonly curable, except in the context of a clinical study.


Clinical Results

Pretreatment with Ethyol significantly reduced the cumulative renal toxicity associated with multiple cycles of chemotherapy.


Side Effects

The most common adverse effects of Ethyol were vomiting, low blood pressure, somnolence, and sneezing. Vomiting, hypotension, and somnolence were more common with higher drug doses. In a phase I trial, vomiting and somnolence were experienced significantly more frequently by women than men.


Literature References

Spencer, C. and Goa, Karen. Amifostine: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential as a Radioprotector and Cytoxic Chemoprotector. Drugs 50(6): 1001-1031, 1995.




< back to top

Ethyol Drug Information

The Ethyol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.